SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intel Corp. engages in the design, manufacture, and sale of computer products and technologies. It delivers computer, networking, data storage, and communications platforms. The firm operates through the following segments: Client Computing Group (CCG), Data Center and AI (DCAI), Intel Foundry Services (IFS), and All Other. The CCG segment consists of platforms designed for notebooks, 2-in-1 systems, desktops, tablets, phones, wireless and wired connectivity products, and mobile communication components. The DCAI segment delivers solutions to cloud service providers and enterprise customers, along with silicon devices for communications service providers and high-performance computing customers. The IFS segment refers to full stack solutions created from the foundry industry ecosystem. The All Other segment represents results from other non-reportable segments and corporate-related charges. The company was founded by Robert Norton Noyce and Gordon Earle Moore on July 18, 1968, and is headquartered in Santa Clara, CA.

Intel Corp.

Intel Corp

Intel is rallying as investors react to a strategic $14.2 billion deal to regain full ownership of its Ireland-based Fab 34, a move perceived as a major vote of confidence in the company's manufacturing and AI-driven growth trajectory. The community is actively debating the stock's future, with many interpreting the heavy capital reinvestment as a clear indicator that major new customer contracts are imminent.

Soleno Therapeutics, Inc. operates as clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. It focuses on the treatment of metabolic and neurobehavioral disorder. It offers its lead candidate, Diazoxide Choline Controlled-Release (DCCR), an oral tablet for the treatment of Prader-Willi Syndrome (PWS). The company was founded on August 25, 1999 and is headquartered in Redwood City, CA.

Soleno Therapeutics Inc

Soleno Therapeutics is currently trending following news that it has secured FDA approval for VYKAT XR, the first therapy developed to treat hyperphagia in Prader-Willi syndrome. The community is actively discussing the stock's significant price momentum, debating the potential for a future acquisition by a larger pharmaceutical player, and evaluating the long-term commercial execution of this newly approved asset.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is trending as the market reacts to the company's latest subscription price hikes, which analysts view as a strategic move to fund a massive content budget and solidify profitability. While some retail investors are voicing frustration over recurring cost increases, the community is heavily focused on the stock's relative strength and technical breakout potential, with many discussing its role as a hedge against broader market volatility.

“Buttcoin - The Next Bitcoin” is the memecoin version of Bitcoin. Launched on January 30, 2025, on Pump.fun, it’s a community-owned memecoin on Solana. The idea was inspired by a 4:20 minutes long YouTube video from 2013 called "The Next Bitcoin?" by James D. McMurray.

The Next Bitcoin

Investors are rallying behind this Solana-based meme coin as a satirical movement intended to mock established market structures, with community members actively comparing its long-term potential to industry giants. Discussions are currently dominated by enthusiasts promoting the token's cultural narrative and its goal of creating viral engagement within the broader crypto ecosystem.

Neurocrine Biosciences, Inc. is a neuroscience-focused, biopharmaceutical company, which engages in the research and development, commercialization, and sale of pharmaceuticals for the treatment of neurological, neuroendocrine, and neuropsychiatric disorders. Its portfolio of products includes treatments for tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia (CAH), and endometriosis and uterine fibroids. The company was founded by Kevin C. Gorman and Wylie W. Vale in January 1992 and is headquartered in San Diego, CA.

Neurocrine Biosciences, Inc.

Neurocrine Biosciences is trending as the market reacts to the definitive agreement to acquire Soleno Therapeutics for $2.9 billion. Community sentiment is mixed, with active debate regarding whether the acquisition effectively addresses Neurocrine's need for pipeline growth or if the premium paid for the rare-disease asset signals a strategic overpay.

Altria Group, Inc. is a holding company, which engages in the manufacture and sale of cigarettes in the United States. It operates through the following segments: Smokeable Products, Oral Tobacco Products, and All Other. The Smokeable Products segment consists of cigarettes manufactured and sold by PM USA, and machine-made large cigars and pipe tobacco manufactured and sold by Middleton. The Oral Tobacco Products segment includes MST and snus products manufactured and sold by USSTC, and oral nicotine pouches manufactured and sold by Helix. The All Other segment refers to the financial results of NJOY, Helix ROW, and the IQOS System heated tobacco business. The company was founded in 1919 and is headquartered in Richmond, VA.

Altria Group Inc.

Altria Group is seeing significant investor interest driven by a combination of resilient pricing power in its core smokeable business and ongoing momentum in its smoke-free portfolio, particularly with the growth of its on! nicotine pouches. The community is actively debating the company's long-term pivot from traditional cigarettes toward smoke-free alternatives, with many highlighting the stock's role as a classic, high-yield defensive play in a volatile market.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is experiencing a significant surge in momentum as the company reports positive trial results for its essential tremor and epilepsy therapies, driving multiple analyst price target upgrades. While the community is debating the impact of a recent large-scale public offering, many investors remain bullish on the long-term potential of the company's CNS-focused pipeline.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders analyze the strategic implications of parent company Centurium Capitals acquisition of Blue Bottle Coffee. While the community remains divided over potential conflicts of interest versus synergistic growth, investors are closely monitoring for signs of a long-anticipated U.S. exchange relisting and are actively debating the stock's future valuation amid shifting institutional ownership.

A2Z Cust2Mate Solutions Corp. is a technology company, which engages in the development and commercialization of retail smart cart solutions for large grocery stores and supermarkets. It operates through the Smart Carts and Precision Metal Parts segments. The Smart Carts segment offers retail automation solutions. Its platform enables seamless in-cart scanning and payment, allowing shoppers to bypass checkout lines while receiving real-time customized offers and product recommendations. The Precision Metal Parts segment includes the manufacturing and sale of precision metal parts. The company was founded by Joseph Bentsur on January 15, 2018 and is headquartered in Vancouver, Canada.

A2Z Cust2Mate Solutions Corp.

A2Z Smart Technologies Corp.

A2Z Smart Technologies is trending following a major five-year strategic agreement to deploy 4,000 smart shopping carts at Carrefour Israel, a move the community views as a significant model for global scalability. Investors are actively discussing the company's retail media expansion, potential for recurring revenue, and bullish technical setups, with many highlighting institutional interest from significant fund stakes as a vote of confidence in the stock's long-term growth trajectory.

Regencell Bioscience Holdings Ltd. is a early-stage bioscience company that focuses on research, development and commercialization of Traditional Chinese Medicine for the treatment of neurocognitive disorders and degeneration, specifically Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. The company was founded by Yat-Gai Au on October 30, 2014 and is headquartered in Hong Kong.

Regencell Bioscience Holdings Ltd

Regencell Bioscience is currently trending due to intense speculation surrounding a potential short squeeze, driven by extremely limited share availability for borrowing and surging borrow fees. The community is actively debating the stock's volatility, with many retail traders drawing comparisons to historical meme stock runs while critics emphasize the company's lack of revenue and potential for dilution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>North America and U.S. comparable sales rose 4%, driven by a 3% increase in transactions and a 1% lift in average spending per visit.</li><li>For fiscal 2026, the company expects global and U.S. comparable store sales growth of at least 3%, with net revenue rising at a similar pace.</li><li>Starbucks plans to open about 600 to 650 net new stores worldwide in fiscal 2026.</li></ul>Starbucks shares rose more than 7% in premarket trading on Wednesday after the coffee giant delivered U.S. comparable transaction growth for the first time in eight quarters.North America and the U.S. comparable sales rose 4%, driven by a 3% increase in transactions and a 1% lift in average spending per visit.“What we’re really delighted about is that the North American comp result is driven by transactions and specifically the fact that both non-rewards customers and rewards customers grew transactions. So, two things happened: people came back to the brand, and we also drove engagement with our existing customers,” Brian Niccol, chairman and CEO, said in a call with analysts.<h2 class="st-heading-2">FY2026 Outlook</h2>For fiscal 2026, the company expects global and U.S. comparable store sales growth of at least 3%, with net revenue rising at a similar pace.It also forecast a slight year-over-year improvement in non-GAAP operating margin and earnings per share of $2.15 to $2.40. Starbucks plans to open about 600 to 650 net new stores worldwide.<h2 class="st-heading-2">Q1 Revenue Beats Estimates</h2>Starbucks posted a 5.5% increase in first-quarter (Q1) revenue to $9.92 billion, which also came above Wall Street estimates of $9.65 billion, according to Fiscal.ai data. However, earnings of $0.26 per share were significantly below Street estimates of $0.59 per share.The company said operating margin fell to 9% due to higher labor spending tied to the “Back to Starbucks” strategy and inflation pressures from elevated coffee prices and tariffs. Starbucks earmarked $500 million for the “Back to Starbucks” strategy to improve staffing, service, and operations.“Our Q1 results demonstrate our ‘Back to Starbucks’ strategy is working, and we believe we’re ahead of schedule,” Niccol added, pointing to renewed sales momentum.International comparable sales grew 5%, led by higher traffic and ticket sizes, while China posted a stronger 7% increase driven by a 5% jump in transactions. Net revenue from China rose 11% to $823.4 million as store count increased 4% to 8,011 locations.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment on Stocktwits flipped to ‘extremely bullish’ from ‘bearish’ a day earlier, amid ‘extremely high’ message volumes. <a href="https://stocktwits.com/symbol/SBUX">SBUX</a> was among the top trending tickers on the platform at the time of writing.<img src="https://news.stocktwits-cdn.com/SBUX_jpg_77a36f8141.webp" alt="SBUX.jpg">One user sounded bullish about the sector.<stembedurl>https://stocktwits.com/CDML115/message/643116424</stembedurl>Another user expects the stock to climb to $120.It is currently trading around $103.<stembedurl>https://stocktwits.com/Srinivas111/message/643117843</stembedurl>Over the past year, the stock has declined by around 3%.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/why-bio-key-bkyi-stock-is-up-today-cybersecurity-deal/cmygd2dR40c">This Nano Cap&nbsp;Cybersecurity&nbsp;Stock Surged Over 70% In Pre-Market Today – What Is The Portugal Connection?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

The Starbucks app page is displayed on a smartphone in front of the Starbucks corporate logoStarbucks has appointed Amazon tech leader Anand Varadarajan as its CTO. (Photo by Cheng Xin/Getty Images)

SBUX Stock Jumps 7% Today – US Transactions Grow For The First Time In Two Years

Starbucks posted a 5.5% increase in first-quarter revenue to $9.92 billion, which also came above Wall Street estimates of $9.65 billion, according to Fiscal.ai data.

Equity

Shares of Peloton Interactive, Inc. (<a class="mention" data-mention="$PTON" data-symbol-id="PTON" href="https://stocktwits.com/symbol/PTON" target="_blank">$PTON</a>) surged nearly 12% on Friday, drawing the attention of retail investors as well.As of 11:00 AM ET, PTON ranked among the top five trending tickers on Stocktwits, with retail sentiment shifting to ‘extremely bullish’ (88/100) from ‘neutral’ the day before.<figure class="image"><a href="https://stocktwits.com/symbol/PTON"><img style="aspect-ratio:1322/328;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_10_18_at_9_10_46_PM_416dabc0ee.png" alt="Screenshot 2024-10-18 at 9.10.46 PM.png" width="1322" height="328"></a><figcaption>PTON sentiment and message volume on Oct 18, as of 11:45 am ET | source: Stocktwits</figcaption></figure>Peloton announced that it will release its fiscal Q1 2025 results before the U.S. stock market opens on Thursday, Oct. 31. The company will host a conference call and live audio webcast to discuss the results at 8:30 AM.According to The Fly, bullish option activity was noted on Thursday, with 43,026 call options traded — twelve times the expected volume — leading to a 25-point increase in implied volatility, now at 133.49%.The most active options included the Nov-24 $6 calls and Oct-24 $5.5 calls, with total volume in these strikes approaching 17,300 contracts. The Put/Call Ratio stands at 0.04.Analysts predict Peloton will report a Q1 loss of $0.15 per share, an improvement from the $0.44 loss recorded in the same period last year.Revenue is expected to decline to $573.26 million, down from $595.5 million year-over-year.In August, Peloton posted Q4 results indicating its first quarterly revenue growth in 2.5 years, driven by a 2% increase in app subscription sales, which offset a 4% decline in hardware product revenue.Despite these signs of recovery, Peloton faces challenges, including ongoing dips in sales of its signature bikes and treadmills, declining expectations for hardware and app subscribers amid economic uncertainties, and the search for a permanent CEO.Market optimism has bolstered following recent management developments.Earlier this month, Peloton announced a partnership with Truemed, which allows eligible U.S.-based customers to use pre-tax Health Savings Account (HSA) and Flexible Spending Account (FSA) dollars to purchase Peloton products at attractive prices.BMO Capital has maintained a ‘Market Perform’ rating with a $6.50 price target on Peloton, noting that recent meetings with the company’s management were “upbeat.”The discussions highlighted a balanced focus on sustainable profits while exploring growth opportunities, including Peloton’s new and improved product offerings like Strength+ (a collection of strength training programs and classes), pricing strategies, cost savings, instructor initiatives, and the ongoing CEO search.So far this year, PTON stock has declined by over 0.15%.Read next: <a href="https://stocktwits.com/news-articles/markets/equity/aapl-stock-rises-after-positive-china-data/cJ22j6bRI8">Apple Stock Perks Up On iPhone China Sales Report: Retail Optimism Rises</a>

Peloton acknowledged ongoing challenges: sales of signature bikes and treadmills continued to dip. Photo courtesy: Peloton

Peloton Stock Gains Momentum, Retail Attention As Earnings Near: Here’s What Analysts Expect

Peloton announced that it will release its fiscal Q1 2025 results before the U.S. stock market opens on Thursday, Oct. 31.

Peloton Interactive Inc (PTON) shares soared as much as 28% on Thursday, marking their biggest one-day jump in over a year after the company's quarterly earnings report, which hinted at a potential comeback.Retail investors turned ecstatic, driving the sentiment score on Stocktwits to ‘extremely bullish’ (94/100) – the highest level this year.<figure class="image"><a href="https://stocktwits.com/symbol/PTON"><img style="aspect-ratio:1320/318;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/PTON_sentiment_and_message_volume_Aug_22_6751a22665.png" alt="PTON sentiment and message volume Aug 22.png" width="1320" height="318"></a><figcaption>PTON sentiment and message volume Aug 22</figcaption></figure>This earnings report, the first since former CEO Barry McCarthy stepped down earlier this year, offered some positive signs for Peloton's turnaround strategy led by two board members.Sales finally increased for the first time in nine quarters, indicating an end to the downward trend. June-quarter losses significantly shrunk by 87% to $30.5 million, showcasing progress towards profitability.The key subscription segment saw a 2.3% revenue rise and a 1% point improvement in gross margin. Peloton generated positive free cash flow of $26 million, compared to negative figures in previous quarters.Still, Peloton acknowledged ongoing challenges: sales of signature bikes and treadmills continuing to dip; expectations of hardware and app subscribers declining based on economic uncertainties; and the ongoing hunt for a permanent CEO.Despite these hurdles, retail investors on Stocktwits expressed strong confidence in Peloton's future.<stembedurl>https://stocktwits.com/Furgersen7/message/583788877</stembedurl>They praised the company's cost-cutting measures and focus on cash flow generation.<stembedurl>https://stocktwits.com/mulder35/message/583776075</stembedurl>Some even compared Peloton's potential turnaround to the recent success story of Carvana, the used-car retailer that reported its first-ever annual profit earlier this year and has since been on a mission to strengthen its balance sheet.<stembedurl>https://stocktwits.com/Tigerrouse111/message/583790791</stembedurl>In the coming months, investors are likely to keep an eye on Peloton's ability to retain and grow its subscriber base, the impact of the broader economic climate on consumer spending and the appointment of a new CEO in the coming months.But for now, they have regained full confidence in the stock that last saw its heyday during the COVID-19 pandemic in 2021.&nbsp;&nbsp;&nbsp;&nbsp;

Peloton Stock Rallies On Turnaround Signs, Retail Investors Turn ‘Extremely Bullish’

PTON stock surged after better-than-expected earnings, which highlighted a decrease in losses, growth in the subscription segment, and improved cash flow.

Global X Funds - Global X Millennial Consumer ETF

Opendoor ($OPEN)

Strategy ($MSTR)

American Eagle ($AEO)

Ondas Inc. ($ONDS)

The stock that proved the power of the crowd. Fueled by community energy and social momentum, this winner captivated retail investors regardless of what the "experts" or traditional fundamentals had to say.

MILN
Global X Funds - Global X Millennial Consumer ETF

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MILN News

MILNGlobal X Funds - Global X Millennial Consumer ETF